Individualizing Treatment for Asthma in Primary Care
Status:
COMPLETED
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
This is a patient level randomized trial for teenagers and adults with asthma who will be randomized to four arms - enhance usual care, rescue inhaled corticosteroids, azithromycin and both rescue inhaled corticosteroids and azithromycin. Participants in all arms will be offered access to an online asthma symptom monitoring system.
Phase:
PHASE4
Details
Lead Sponsor:
DARTNet Institute
Collaborators:
Brigham and Women's Hospital Icahn School of Medicine at Mount Sinai Kelsey Research Foundation Penn State University RAND Reliant Medical Group Rutgers University University of Colorado, Denver University of North Carolina University of Washington Wake Forest University Health Sciences